Live Breaking News & Updates on Manufacturer Serum Institute Of India

Stay updated with breaking news from Manufacturer serum institute of india. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

India should fix its vaccine pricing strategy to save its economy


India should fix its vaccine pricing strategy to save its economy
Quartz
4 hrs ago
© Provided by Quartz
COVID-19 vaccinatin in Mumbai
A functioning vaccination program would appear to be the strongest weapon for halting the unrelenting march of India’s second Covid-19 wave. And yet, it is in a state of total disarray. The government’s failure to effectively negotiate prices and procurement could not only cost lives, but devastate the economy too.
On May 1, India will open up its Covid-19 vaccine drive to all people over the age of 18. In this phase, makers of authorized vaccines will be able to directly sell 50% of their stock to state governments and private hospitals. ....

United Kingdom , Uttar Pradesh , Nirmala Sitharaman , Adar Poonawalla , Tata Institute Of Social Sciences , Indian Council For Medical Research , Manufacturer Serum Institute Of India , Serum Institute , Bharat Biotech , Indian Council , Medical Research , Tata Institute , ஒன்றுபட்டது கிஂக்டம் , உத்தர் பிரதேஷ் , அடார் பூனாவல்ல , டாடா நிறுவனம் ஆஃப் சமூக அறிவியல் , இந்தியன் சபை க்கு மருத்துவ ஆராய்ச்சி , சீரம் நிறுவனம் , பாரத் பயோடெக் , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி , டாடா நிறுவனம் ,

India should fix its vaccine pricing strategy to save its economy — Quartz India


April 27, 2021
A functioning vaccination program would appear to be the strongest weapon for halting the unrelenting march of India’s second Covid-19 wave. And yet, it is in a state of total disarray. The government’s failure to effectively negotiate prices and procurement could not only cost lives, but devastate the economy too.
On May 1, India will open up its Covid-19 vaccine drive to all people over the age of 18. In this phase, makers of authorized vaccines will be able to directly sell 50% of their stock to state governments and private hospitals.
In this new phase, it is up to state governments to decide whether all Indians could get their vaccines for free; the federal government already offers free shots for over 45s (plus frontline and healthcare workers). ....

Uttar Pradesh , United Kingdom , Nirmala Sitharaman , Adar Poonawalla , Tata Institute Of Social Sciences , Indian Council For Medical Research , Manufacturer Serum Institute Of India , Serum Institute , Bharat Biotech , Indian Council , Medical Research , Tata Institute , Narendra Modi , Covid 19 , Corona Virus , Coronavirus India , Edited By Hasit Shah , India Covid 19 , Covid 19 Vaccine , Serum Institute Of India , India Second Wave , Covid 19 Second Wave , Vaccine Price , உத்தர் பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , அடார் பூனாவல்ல ,